Bevacizumab Plus Fluorouracil and Leucovorin in Treating Patients With Locally Advanced or Metastatic Stage IV Colorectal Cancer That Has Progressed After Standard Chemotherapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Helen X. Chen, MD
NCI - Investigational Drug Branch
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
33 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Jonsson Comprehensive Cancer Center, Ucla
Los Angeles, California, United States
- Usc/norris Comprehensive Cancer Center and Hospital
Los Angeles, California, United States
- University of Colorado Cancer Center at University of Colorado Health Sciences Center
Aurora, Colorado, United States
- Yale Comprehensive Cancer Center
New Haven, Connecticut, United States
- Lombardi Cancer Center
Washington D.C., District of Columbia, United States
- Ccop - Atlanta Regional
Atlanta, Georgia, United States
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Chicago, Illinois, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- Holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- Siouxland Hematology-Oncology
Sioux City, Iowa, United States
- Ccop - Wichita
Wichita, Kansas, United States
- Cancer Care of Maine
Bangor, Maine, United States
- Saint Joseph Mercy Health System
Ann Arbor, Michigan, United States
- St. Mary'S/duluth Clinic Cancer Center
Duluth, Minnesota, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- Ccop - Montana Cancer Consortium
Billings, Montana, United States
- Southern Nevada Cancer Research Foundation
Las Vegas, Nevada, United States
- Norris Cotton Cancer Center
Lebanon, New Hampshire, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- New York Weill Cornell Cancer Center at Cornell University
New York, New York, United States
- Duke Comprehensive Cancer Center
Durham, North Carolina, United States
- Comprehensive Cancer Center at Wake Forest University
Winston-Salem, North Carolina, United States
- Meritcare Roger Maris Cancer Center
Fargo, North Dakota, United States
- Ireland Cancer Center
Cleveland, Ohio, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Kimmel Cancer Center of Thomas Jefferson University - Philadelphia
Philadelphia, Pennsylvania, United States
- Sioux Valley Clinics - Oncology
Sioux Falls, South Dakota, United States
- Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont, United States
- Massey Cancer Center
Richmond, Virginia, United States
- Ccop - Virginia Mason Research Center
Seattle, Washington, United States
- Seattle Cancer Care Alliance
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2003
- Primary completion
- —
- Completion
- 31 Jul 2007
- Last update posted
- 20 Jun 2013
- Registered enrollment
- —
- Registry id
- NCT00066846
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.